Reid G. Adler insider trades
Open-market stock purchases and sales by Reid G. Adler, Chief Legal Officer at Vistagen Therapeutics, Inc, from SEC Form 4 filings since May 2, 2022.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +42%.
Companies traded
- VTGN Vistagen Therapeutics, Inc: 1 buy, last Apr 7, 2026